Adding Leqvio to Crestor Instead of Switching: What to Know
Leqvio adds about 50% more LDL-C reduction on top of Crestor rather than replacing it; the two drugs target different pathways and are often combined.
Cardiometabolic Drug Comparisons
63 source-based articles maintained by the HealthRX.com Editorial Team.
63articles
3topic areas covered
May 25, 2026latest review
Cardiometabolic Drug Comparisons library
Showing 60 of 63 clinical reviews.
Amlodipine vs Atorvastatin Cost: What You'll Actually Pay
Both generics run $4 to $15 a month and sit on Tier 1 of most formularies. Often prescribed together, not as alternatives, for cardiometabolic risk.
Can Leqvio Be Added to Lipitor? Combo Explained
Yes, Leqvio (inclisiran) can be added to Lipitor (atorvastatin) rather than replacing it, adding about 50% more LDL-C reduction on top of the statin.
Can Leqvio Be Added to Lipitor? Cost and Access Guide
Yes, Leqvio is typically added to maximally tolerated statins like atorvastatin when LDL-C goals aren't met. Compare costs, dosing, and prior authorization needs.
Can Leqvio Be Added to Lipitor? Efficacy Compared
Yes, inclisiran (Leqvio) is added on top of atorvastatin (Lipitor), cutting LDL-C ~50% more with no head-to-head trial data yet available.
Crestor vs Amlodipine: Side-Effect Profile Head-to-Head
A clinical comparison of rosuvastatin (Crestor) and amlodipine side effects, tolerability data, and discontinuation rates from major cardiovascular trials.
Crestor vs Leqvio: Switching Between Rosuvastatin and Inclisiran
A clinical comparison of Crestor (rosuvastatin) and Leqvio (inclisiran) covering mechanism, efficacy, cost, and how to switch between them safely under physician guidance.
Crestor vs Lisinopril: Side-Effect Profile Head-to-Head
A clinical comparison of rosuvastatin (Crestor) and lisinopril side effects, backed by JUPITER, ALLHAT, and post-market safety data. Learn which drug causes fewer adverse events and how to manage common reactions.
Crestor vs Losartan: Can You Switch Between Them?
Rosuvastatin (Crestor) and losartan treat different cardiometabolic risks. Learn what each drug does, whether switching is safe, and how your doctor decides which you need.
Crestor vs Losartan: Side-Effect Profile Head-to-Head
A clinical comparison of rosuvastatin (Crestor) and losartan side effects, covering muscle symptoms, kidney impact, metabolic changes, and tolerability data from JUPITER and LIFE trials.
Crestor vs Repatha Side Effects: Rosuvastatin vs Evolocumab Head-to-Head Safety Comparison
Compare the side-effect profiles of Crestor (rosuvastatin) and Repatha (evolocumab) using data from JUPITER, FOURIER, and post-marketing surveillance. Covers muscle symptoms, injection-site reactions, liver effects, diabetes risk, and cognitive concerns.
Crestor vs Repatha: Head-to-Head Efficacy Comparison
Rosuvastatin (Crestor) and evolocumab (Repatha) both lower LDL cholesterol and reduce cardiovascular events, but they work differently, cost differently, and serve different patient populations. This evidence-based comparison breaks down JUPITER vs FOURIER trial data, LDL reduction, side effects, and when clinicians prescribe one or both.
Crestor vs Repatha: Switching Between Rosuvastatin and Evolocumab
Repatha vs rosuvastatin: both lower LDL but by different mechanisms. Most start on rosuvastatin; Repatha is usually added on top, or used if statins fail.
Crestor vs Zetia: Head-to-Head Efficacy Compared
An evidence-based comparison of rosuvastatin (Crestor) and ezetimibe (Zetia) covering LDL reduction, cardiovascular outcomes evidence, side effects, and how clinicians actually sequence these two drugs.
Crestor vs Zetia: How to Switch Between Rosuvastatin and Ezetimibe Safely
Zetia (ezetimibe) blocks intestinal cholesterol absorption and lowers LDL by 18 to 20 percent alone, or 60 to 65 percent taken with Crestor (rosuvastatin).
Is Lisinopril a Statin? No, Here's the Difference
Lisinopril is not a statin. It's an ACE inhibitor for blood pressure, while atorvastatin lowers cholesterol. Both generics cost $4 to $15 monthly.
Is Rosuvastatin a Calcium Channel Blocker? No, It's a Statin
Rosuvastatin is a statin that lowers LDL cholesterol, not a calcium channel blocker. Amlodipine handles blood pressure; many patients need both drugs together.
LDL Still High on Rosuvastatin + Ezetimibe? Add Inclisiran
Yes, adding inclisiran can lower LDL-C by another 50 to 52% via a different pathway, often reaching goal when statin plus ezetimibe alone falls short.
Leqvio Annual Cost vs Lisinopril Cost and Access
Leqvio costs about $6,500 a year versus $48-$180 for generic lisinopril. Compare list price, out-of-pocket range, dosing, and insurance access.
Leqvio Cost with Medicare Part B, No Supplement
Leqvio is Part B-covered but coinsurance can still run high without a supplement; list price is about $6,500 per dose, given twice yearly.
Leqvio Safety vs Ezetimibe and Statins: LDL-C Data
Inclisiran lowers LDL-C about 50% with two shots yearly; ezetimibe cuts it 18-20% orally with proven MACE reduction. Compare safety and switching.
Lipitor vs Crestor: Cost, Access, and Clinical Value Compared
A head-to-head comparison of atorvastatin (Lipitor) and rosuvastatin (Crestor) covering generic pricing, insurance formulary placement, LDL-lowering potency, and real-world access barriers.
Lipitor vs Crestor: Switching Between Atorvastatin and Rosuvastatin
Evidence-based guide to switching between Lipitor (atorvastatin) and Crestor (rosuvastatin), including dose equivalency tables, clinical trial data from ASCOT-LLA and JUPITER, and what to expect during the transition.
Lipitor vs Lisinopril: Head-to-Head Efficacy for Cardiometabolic Risk
An evidence-based comparison of atorvastatin (Lipitor) and lisinopril for cardiometabolic outcomes, drawing on ASCOT-LLA, ALLHAT, and current ACC/AHA guidelines.
Lipitor vs Lisinopril: Switching Between Them Safely
No, lisinopril is not a statin. It's an ACE inhibitor that lowers blood pressure. Atorvastatin (Lipitor) is a statin, and statins lower LDL cholesterol.
Lipitor vs Losartan: Cost and Access Head-to-Head Comparison
A detailed comparison of atorvastatin (Lipitor) and losartan covering cost, insurance coverage, generic availability, clinical evidence, and access considerations for cardiometabolic patients.
Lipitor vs Losartan: Side-Effect Profile Head-to-Head
No, losartan is not a statin. It's an angiotensin II receptor blocker that lowers blood pressure, while atorvastatin (Lipitor) is the statin lowering LDL.
Lipitor vs Losartan: Switching Between Them
Atorvastatin and losartan treat different cardiometabolic risks. Learn whether you can switch between Lipitor and Losartan, what each drug does, and how physicians manage transitions.
Lipitor vs Praluent: Head-to-Head Efficacy Comparison
Evidence-based comparison of atorvastatin (Lipitor) and alirocumab (Praluent) for LDL-C lowering and cardiovascular risk reduction, with trial data from ASCOT-LLA and ODYSSEY OUTCOMES.
Lipitor vs Repatha Side Effects: Atorvastatin vs Evolocumab Head-to-Head Safety Comparison
Compare the side-effect profiles of Lipitor (atorvastatin) and Repatha (evolocumab) across muscle symptoms, liver effects, injection-site reactions, and cardiovascular outcomes from ASCOT-LLA and FOURIER trial data.
Lipitor vs Repatha: Cost and Access Head-to-Head Comparison
A clinical comparison of atorvastatin (Lipitor) and evolocumab (Repatha) covering cost, insurance access, efficacy data from ASCOT-LLA and FOURIER, and practical prescribing guidance.
Lipitor vs Repatha: Head-to-Head Efficacy Compared
Evidence-based comparison of atorvastatin (Lipitor) and evolocumab (Repatha) for LDL-C reduction and cardiovascular outcomes, including trial data from ASCOT-LLA, FOURIER, and OSLER-1.
Lipitor vs Repatha: Switching Between Atorvastatin and Evolocumab
Clinical guide to switching between Lipitor (atorvastatin) and Repatha (evolocumab), including when each drug is preferred, how to transition safely, and what trial evidence shows for LDL reduction and cardiovascular outcomes.
Lipitor vs Zetia Side Effects: Atorvastatin vs Ezetimibe Head-to-Head Comparison
A clinical comparison of Lipitor (atorvastatin) and Zetia (ezetimibe) side-effect profiles, backed by trial data from ASCOT-LLA and IMPROVE-IT, with practical guidance on tolerability, switching, and combination therapy.
Lipitor vs Zetia: Cost, LDL Results and Which Comes First
Generic atorvastatin costs $4-15/month and cuts LDL 36-50%; ezetimibe runs $9-30/month for 18-25%. See when Zetia gets added to a statin.
Lipitor vs Zetia: Switching Between Atorvastatin and Ezetimibe
Evidence-based comparison of Lipitor (atorvastatin) and Zetia (ezetimibe), including when and how to switch between them, trial data from ASCOT-LLA and IMPROVE-IT, and clinical guidance for cardiometabolic patients.
Lisinopril vs Amlodipine Side Effects: A Head-to-Head Comparison
Compare the side-effect profiles of lisinopril and amlodipine, two first-line antihypertensives, using ALLHAT, ASCOT-BPLA, and real-world evidence to guide your choice.
Lisinopril vs Amlodipine: Head-to-Head Efficacy Compared
A clinical comparison of lisinopril and amlodipine for blood pressure control and cardiovascular outcomes, drawing on ALLHAT, ASCOT-BPLA, and current guideline evidence.
Lisinopril vs Amlodipine: Switching Between Them Safely
A clinical comparison of lisinopril and amlodipine for blood pressure control, including how to switch between them, what the trial data shows, and what to expect during the transition.
Lisinopril vs Losartan: Switching Between Them Safely
Compare lisinopril and losartan for blood pressure and heart protection. Learn how to switch between them, what doses are approximately equivalent, and which drug fits your clinical profile.
Losartan or Amlodipine for Kidney Health? Compare
Losartan lowers albuminuria, favoring kidney protection in diabetes or CKD; amlodipine lowers BP more. Both cost under $15/month generic.
Losartan Side Effects vs Amlodipine Efficacy Compared
No head-to-head trial exists; amlodipine lowers SBP 2-4 mmHg more, but losartan aids stroke and kidney protection in diabetes. Choice depends on comorbidities.
Losartan vs Amlodipine: Side-Effect Profile Head-to-Head
A detailed comparison of losartan and amlodipine side effects, covering edema, hyperkalemia, dizziness, cough, metabolic impact, and serious adverse events with trial-level evidence.
Losartan vs Amlodipine: Switching Between Them and Which One Is Right for You
A detailed clinical comparison of losartan and amlodipine for hypertension, including how to switch between them safely, trial data from LIFE and ASCOT-BPLA, and guidance on which drug fits which patient profile.
Praluent vs Leqvio: Head-to-Head Efficacy Comparison
An evidence-based comparison of alirocumab (Praluent) and inclisiran (Leqvio) covering LDL-C reduction, cardiovascular outcomes, dosing, safety, and clinical selection criteria.
Praluent vs Leqvio: Switching Between Alirocumab and Inclisiran
Clinical guide to switching between Praluent (alirocumab) and Leqvio (inclisiran), comparing LDL-C reduction, cardiovascular outcomes data, dosing schedules, and practical transition protocols.
Repatha vs Amlodipine: Switching Between Them
Repatha (evolocumab) and amlodipine target different cardiometabolic risks. Learn how PCSK9 inhibitors and calcium channel blockers compare, when switching applies, and how clinicians manage both in practice.
Repatha vs Leqvio Head-to-Head Efficacy: Evolocumab vs Inclisiran Compared
Repatha vs Leqvio: both cut LDL-C about 50% on statin therapy, but only Repatha has proven MACE data (FOURIER); Leqvio needs 2 office injections a year.
Repatha vs Leqvio Side-Effect Profile: Evolocumab vs Inclisiran Head-to-Head
A clinical comparison of Repatha (evolocumab) and Leqvio (inclisiran) side effects, injection-site reactions, musculoskeletal symptoms, and long-term safety data from FOURIER and ORION trials.
Repatha vs Leqvio: Cost, Access, and Clinical Comparison
Leqvio vs Repatha: both cut LDL-C about 50-60%, but Repatha has proven 15% MACE reduction in FOURIER while Leqvio needs only two office injections a year.
Repatha vs Leqvio: Switching Between Them Explained
A comparison of evolocumab (Repatha) and inclisiran (Leqvio), covering mechanism, LDL-C efficacy, MACE outcomes, dosing, and how to switch between them safely.
Repatha vs Losartan: Combining the Two (Rationale + Risk)
Evolocumab (Repatha) lowers LDL-C by 59% while losartan reduces blood pressure and protects the kidneys. Learn why cardiologists often prescribe both, how they interact, and when combining them makes clinical sense.
Repatha vs Praluent Side Effects: Evolocumab vs Alirocumab Head-to-Head Safety Comparison
A detailed comparison of Repatha (evolocumab) and Praluent (alirocumab) side-effect profiles based on FOURIER and ODYSSEY OUTCOMES trial data, injection-site reactions, neurocognitive events, and real-world safety signals.
Repatha vs Praluent: Cost, Access, and Clinical Comparison
Praluent vs Repatha: both cut LDL 50-60% and major cardiovascular events by about 15%. Costs run near $6,000 a year, so formulary and dosing decide it.
Rosuvastatin LDL Reduction Chart vs Atorvastatin
Rosuvastatin 40mg cuts LDL about 55-63%, atorvastatin 80mg about 50-55%. Compare doses, high-intensity thresholds, and trial evidence (JUPITER, ASCOT-LLA).
Switching ACE Inhibitor to ARB: Washout Needed?
No washout is typically required switching lisinopril to losartan; both affect RAAS but cough and angioedema risks drop sharply with the switch.
Warning Labels: Lipitor vs Leqvio Side Effects Compared
Lipitor carries muscle-related warnings (5-10% of users); Leqvio's label centers on mild injection-site reactions (~5%). No head-to-head trial exists yet.
Zetia vs Amlodipine: Combining the Two (Rationale + Risk)
Ezetimibe (Zetia) lowers LDL-C; amlodipine lowers blood pressure. They work through completely different mechanisms, which is exactly why cardiologists often prescribe both at once. This guide explains the science, the evidence, and the real risks of combining them.
Zetia vs Lisinopril: Switching Between Them Safely
Ezetimibe (Zetia) and lisinopril treat different cardiometabolic risks. Learn when switching makes sense, what the evidence says, and how to transition safely under medical supervision.
Zetia vs Praluent Side Effects: Ezetimibe vs Alirocumab Head-to-Head Comparison
A clinical comparison of Zetia (ezetimibe) and Praluent (alirocumab) side-effect profiles, drawing on IMPROVE-IT and ODYSSEY OUTCOMES trial safety data.
Showing the first 60 matches among the loaded articles. Use the page links below to browse the complete library.